Kamalpreet Dhanota, NP
Nurse Practitioner · Yuba City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kamalpreet Dhanota’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$84,199
Medicare paid this office $84,199 for 908 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 679 | $53,926 | $74 |
| New patient visit (45+ min) | 93 | $7,601 | $82 |
| Long return visit (40+ min) | 61 | $6,683 | $110 |
| Short return visit (20+ min) | 77 | $4,163 | $50 |
| Insertion of needle into vein for collection of blood sample | 256 | $2,327 | $9 |
See all 18 services
| Return visit (30+ min) | 679 | $53,926 | $74 |
| New patient visit (45+ min) | 93 | $7,601 | $82 |
| Long return visit (40+ min) | 61 | $6,683 | $110 |
| Short return visit (20+ min) | 77 | $4,163 | $50 |
| Insertion of needle into vein for collection of blood sample | 256 | $2,327 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 143 | $1,253 | $9 |
| Detection test by immunoassay technique for streptococcus, group a (strep) | 49 | $824 | $16 |
| Injection of drug or substance under skin or into muscle | 66 | $650 | $9 |
| Short return visit | 14 | $579 | $36 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 33 | $535 | $16 |
| Automated urinalysis test | 181 | $418 | $2 |
| Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) | 13 | $394 | $30 |
| Administration of vaccine | 24 | $336 | $14 |
| Diphtheria and tetanus vaccine (7 years or older) | 11 | $202 | $18 |
| Removal of impacted ear wax by washing | 16 | $167 | $10 |
| Injection, ketorolac tromethamine, per 15 mg | 12 | $22 | None |
| Injection, ceftriaxone sodium, per 250 mg | 15 | $20 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 16 | $5 | None |
Who their Medicare patients are
908 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 14% · Women 64% · Also on Medicaid 20% · Health risk score 1.17. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 37% · Coronary heart disease 31% · Chronic kidney disease 27% · Depression 23% · COPD 21% · Atrial fibrillation 19% · Heart failure 18% · Cancer 13% · Stroke 8% · Dementia 5%.
The office billed $432,922, Medicare allowed $126,058 and paid $84,199; for 2,175 services of 55 kinds; $714 of it was for drugs given in the office and $83,485 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 908 | 2,175 | 75 | 1.17 | $432,922 | $84,199 |
| 2023 | 792 | 1,920 | 74 | 1.15 | $351,280 | $77,294 |
| 2022 | 833 | 1,883 | 74 | 1.11 | $339,387 | $73,134 |
| 2021 | 656 | 1,365 | 73 | 1.19 | $247,867 | $59,060 |
| 2020 | 429 | 961 | 72 | 1.24 | $154,791 | $33,046 |
| 2019 | 390 | 904 | 72 | 1.22 | $135,351 | $30,129 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Return visit (30+ min) | 593 | $51,561 | $80 |
| New patient visit (45+ min) | 69 | $6,566 | $95 |
| Short return visit (20+ min) | 91 | $4,933 | $51 |
| Long return visit (40+ min) | 36 | $3,947 | $110 |
| Insertion of needle into vein for collection of blood sample | 235 | $2,033 | $8 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 59 | $956 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 94 | $923 | $10 |
| New patient visit (30+ min) | 13 | $793 | $61 |
| Injection of drug or substance under skin or into muscle | 59 | $648 | $10 |
| Automated urinalysis test | 198 | $464 | $2 |
| Detection test by immunoassay with direct visual observation for influenza virus | 16 | $292 | $16 |
| Diphtheria and tetanus vaccine (7 years or older) | 11 | $250 | $23 |
| Removal of impacted ear wax by washing | 17 | $178 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $51 | None |
| Injection, cefazolin sodium, 500 mg | 18 | $24 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 15 | $6 | None |
2022: 15 services
| Return visit (30+ min) | 610 | $49,941 | $76 |
| Short return visit (20+ min) | 108 | $6,662 | $57 |
| New patient visit (45+ min) | 63 | $5,406 | $86 |
| Long return visit (40+ min) | 27 | $3,341 | $124 |
| New patient visit (30+ min) | 29 | $1,603 | $55 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 52 | $848 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 76 | $669 | $9 |
| Injection of drug or substance under skin or into muscle | 72 | $656 | $9 |
| Insertion of needle into vein for collection of blood sample | 184 | $557 | $3 |
| Automated urinalysis test | 180 | $427 | $2 |
| Detection test by immunoassay with direct visual observation for influenza virus | 22 | $359 | $16 |
| Injection, ketorolac tromethamine, per 15 mg | 24 | $37 | None |
| Injection, hydromorphone, up to 4 mg | 13 | $33 | None |
| Injection, ceftriaxone sodium, per 250 mg | 13 | $14 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 20 | $5 | None |
2021: 14 services
| Return visit (30+ min) | 448 | $39,825 | $83 |
| Short return visit (20+ min) | 102 | $6,074 | $57 |
| Long return visit (40+ min) | 30 | $3,312 | $110 |
| New patient visit (30+ min) | 46 | $2,818 | $61 |
| New patient visit (45+ min) | 29 | $2,697 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 59 | $542 | $9 |
| Injection of drug or substance under skin or into muscle | 57 | $531 | $9 |
| Insertion of needle into vein for collection of blood sample | 135 | $411 | $3 |
| Automated urinalysis test | 147 | $344 | $2 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 19 | $314 | $17 |
| Injection, promethazine hcl, up to 50 mg | 15 | $30 | None |
| Injection, hydromorphone, up to 4 mg | 12 | $29 | None |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $17 | None |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $12 | None |
2020: 11 services
| Return visit (30+ min) | 342 | $24,506 | $70 |
| New patient visit (30+ min) | 47 | $2,928 | $62 |
| Short return visit (20+ min) | 43 | $1,956 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 45 | $501 | $11 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 23 | $378 | $16 |
| Injection of drug or substance under skin or into muscle | 37 | $349 | $9 |
| Detection test by immunoassay with direct visual observation for influenza virus | 18 | $294 | $16 |
| Insertion of needle into vein for collection of blood sample | 92 | $275 | $3 |
| Automated urinalysis test | 83 | $186 | $2 |
| Injection, promethazine hcl, up to 50 mg | 11 | $19 | None |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $18 | None |
2019: 12 services
| Return visit (30+ min) | 311 | $22,517 | $71 |
| Short return visit (20+ min) | 42 | $2,170 | $50 |
| New patient visit (30+ min) | 32 | $1,953 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 56 | $642 | $11 |
| Injection of drug or substance under skin or into muscle | 35 | $401 | $11 |
| Insertion of needle into vein for collection of blood sample | 101 | $300 | $3 |
| Detection test by immunoassay with direct visual observation for influenza virus | 15 | $243 | $16 |
| Automated urinalysis test | 98 | $239 | $2 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 14 | $227 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 16 | $195 | $12 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $19 | None |
| Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | 11 | $3 | None |
Medicaid work
$116 in 2024
Medicaid paid $116 for 13 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $116 |
| 2024 | 13 | 1 | 12 | $116 |
Drugs they prescribed that Part D paid
$7,520
Pharmacies billed $7,520 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (16 of 615) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
568 generic and fewer than 11 brand-name prescriptions · $7,520 in drug cost · 386 antibiotic prescriptions to 345 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cefdinir | 52 | $867 | $16 |
| Doxycycline Hyclate | 124 | $812 | $6 |
| Albuterol Sulfate Hfa | 25 | $568 | $23 |
| Amoxicillin-Clavulanate Potass | 88 | $539 | $6 |
| Cephalexin | 55 | $290 | $5 |
See all 12 drugs
| Cefdinir | 52 | $867 | $16 |
| Doxycycline Hyclate | 124 | $812 | $6 |
| Albuterol Sulfate Hfa | 25 | $568 | $23 |
| Amoxicillin-Clavulanate Potass | 88 | $539 | $6 |
| Cephalexin | 55 | $290 | $5 |
| Mupirocin | 20 | $119 | $6 |
| Tobramycin | 17 | $72 | $4 |
| Ciprofloxacin | 15 | $67 | $4 |
| Prednisone | 33 | $57 | $2 |
| Azithromycin | 13 | $47 | $4 |
| Hydrocodone-Acetaminophen | 12 | $39 | $3 |
| Amoxicillin | 12 | $24 | $2 |
Year by year
| 2024 | 615 | 436 | 3% (16) | None | $7,520 |
| 2023 | 569 | 441 | 4% (20) | 3% | $6,818 |
| 2022 | 618 | 439 | 4% (26) | None | $17,848 |
| 2021 | 468 | 340 | 3% (16) | 4% | $7,517 |
| 2020 | 350 | 248 | 6% (20) | 7% | $4,847 |
| 2019 | 382 | 268 | 5% (18) | 7% | $7,048 |
| 2018 | 279 | 194 | 4% (12) | None | $4,545 |
| 2017 | 516 | 363 | 6% (33) | 6% | $7,343 |
| 2016 | 403 | 296 | 6% (25) | 10% | $5,857 |
| 2015 | 27 | 20 | None | None | $316 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Doxycycline Hyclate | 108 | $1,604 | $15 |
| Cefdinir | 49 | $1,033 | $21 |
| Amoxicillin-Clavulanate Potass | 73 | $758 | $10 |
| Cephalexin | 60 | $521 | $9 |
| Albuterol Sulfate Hfa | 11 | $316 | $29 |
| Azithromycin | 27 | $134 | $5 |
| Paxlovid (Eua) | 13 | $131 | $10 |
| Mupirocin | 21 | $128 | $6 |
| Ciprofloxacin | 16 | $90 | $6 |
| Amoxicillin | 19 | $75 | $4 |
| Hydrocodone-Acetaminophen | 16 | $68 | $4 |
| Prednisone | 20 | $38 | $2 |
2022: 12 drugs
| Doxycycline Hyclate | 119 | $2,323 | $20 |
| Cefdinir | 58 | $1,094 | $19 |
| Albuterol Sulfate Hfa | 31 | $1,044 | $34 |
| Amoxicillin-Clavulanate Potass | 59 | $618 | $10 |
| Fluticasone Propionate | 22 | $286 | $13 |
| Cephalexin | 31 | $152 | $5 |
| Azithromycin | 30 | $137 | $5 |
| Mupirocin | 16 | $109 | $7 |
| Hydrocodone-Acetaminophen | 22 | $105 | $5 |
| Amoxicillin | 28 | $99 | $4 |
| Prednisone | 33 | $83 | $3 |
| Ciprofloxacin | 13 | $76 | $6 |
2021: 10 drugs
| Doxycycline Hyclate | 47 | $1,139 | $24 |
| Cefdinir | 66 | $1,061 | $16 |
| Albuterol Sulfate Hfa | 18 | $699 | $39 |
| Amoxicillin-Clavulanate Potass | 48 | $580 | $12 |
| Fluticasone Propionate | 21 | $353 | $17 |
| Azithromycin | 32 | $205 | $6 |
| Cephalexin | 29 | $143 | $5 |
| Hydrocodone-Acetaminophen | 15 | $66 | $4 |
| Ciprofloxacin | 11 | $60 | $5 |
| Prednisone | 17 | $50 | $3 |
2020: 8 drugs
| Doxycycline Hyclate | 61 | $1,059 | $17 |
| Cefdinir | 41 | $800 | $20 |
| Fluticasone Propionate | 25 | $268 | $11 |
| Amoxicillin-Clavulanate Potass | 24 | $243 | $10 |
| Azithromycin | 20 | $130 | $6 |
| Cephalexin | 22 | $93 | $4 |
| Mupirocin | 12 | $72 | $6 |
| Hydrocodone-Acetaminophen | 17 | $66 | $4 |
2019: 9 drugs
| Cefdinir | 50 | $1,155 | $23 |
| Doxycycline Hyclate | 32 | $535 | $17 |
| Fluticasone Propionate | 38 | $531 | $14 |
| Doxycycline Monohydrate | 40 | $466 | $12 |
| Amoxicillin-Clavulanate Potass | 30 | $366 | $12 |
| Azithromycin | 23 | $187 | $8 |
| Cephalexin | 23 | $174 | $8 |
| Ciprofloxacin | 14 | $97 | $7 |
| Hydrocodone-Acetaminophen | 11 | $44 | $4 |
2018: 6 drugs
| Fluticasone Propionate | 29 | $571 | $20 |
| Doxycycline Monohydrate | 51 | $550 | $11 |
| Amoxicillin-Clavulanate Potass | 17 | $179 | $11 |
| Azithromycin | 17 | $126 | $7 |
| Cephalexin | 23 | $105 | $5 |
| Amoxicillin | 11 | $54 | $5 |
2017: 10 drugs
| Cefdinir | 26 | $635 | $24 |
| Doxycycline Monohydrate | 68 | $634 | $9 |
| Fluticasone Propionate | 28 | $617 | $22 |
| Amoxicillin-Clavulanate Potass | 34 | $373 | $11 |
| Azithromycin | 46 | $239 | $5 |
| Cephalexin | 29 | $222 | $8 |
| Ciprofloxacin | 40 | $186 | $5 |
| Hydrocodone-Acetaminophen | 26 | $127 | $5 |
| Prednisone | 19 | $49 | $3 |
| Sulfamethoxazole-Trimethoprim | 12 | $35 | $3 |
2016: 12 drugs
| Doxycycline Hyclate | 21 | $624 | $30 |
| Fluticasone Propionate | 22 | $535 | $24 |
| Cefdinir | 16 | $491 | $31 |
| Amoxicillin-Clavulanate Potass | 22 | $330 | $15 |
| Nitrofurantoin Mono-Macro | 18 | $330 | $18 |
| Azithromycin | 49 | $289 | $6 |
| Ciprofloxacin | 29 | $287 | $10 |
| Cephalexin | 21 | $194 | $9 |
| Doxycycline Monohydrate | 16 | $184 | $12 |
| Hydrocodone-Acetaminophen | 19 | $113 | $6 |
| Sulfamethoxazole-Trimethoprim | 18 | $92 | $5 |
| Amoxicillin | 12 | $63 | $5 |
Money from drug and device companies
$26 in 2025
A payment is not proof that care is biased.
| Vertex Pharmaceuticals | Journavx | $26 | 1 payment
|
See the published payment
| Vertex Pharmaceuticals | Meals · 2025-08-28 | Journavx | $26 |
Professional record
- NPI
- 1235507286
- Licence
- CA NP95002493
- Group
- Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Student in a training program (390200000X)
- Mailing address
- 10470 Old Placerville Rd, Sacramento, CA, 95827
- NPI first listed
- 2015-09-08
- NPI last updated
- 2015-11-20
This is when the NPI record was last certified, not a medical board exam.